Sovereign Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Sovereign Financial Group's BMY Position: Q2 2026 in Review
Sovereign Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 3.1% in Q2 2026, selling an estimated $24.4K and leaving 13,116 shares worth $756K. The position accounts for 0.12% of the portfolio, ranked #163.
Sovereign Financial Group first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.01M in Q1 2023. 945 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Sovereign Financial Group held 13,116 shares of Bristol-Myers Squibb worth $756K as of Q2 2026.
- Sovereign Financial Group sold 425 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.4K.
- Bristol-Myers Squibb made up 0.12% of Sovereign Financial Group's portfolio in Q2 2026, its #163 holding.
- Sovereign Financial Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
- Sovereign Financial Group's Bristol-Myers Squibb position peaked at $1.01M in Q1 2023.
- 945 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Sovereign Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.